Target intelligence / Profile preview

Procollagen C-endopeptidase enhancer 2 (PCPE2)

Target
PCPE2
Molecular classification
Other (matricellular protein; non-enzymatic enhancer/regulator of proteolytic activity), Extracellular matrix protein, Collagen/interactor modulator
01

Overview

Procollagen C-endopeptidase enhancer 2 (PCPE2) is a secreted extracellular matrix protein that binds to the C-terminal propeptide of types I and II procollagen, regulating the cleavage and maturation of collagen molecules primarily by potentiating or modulating the activity of the metalloprotease bone morphogenetic protein-1 (BMP1) and related enzymes. PCPE2 exhibits distinct glycosylation and stronger heparin affinity than its paralog PCPE1, and is particularly expressed in nonossified cartilage and adult heart tissue. Beyond its role in collagen maturation, PCPE2 is implicated in lipid metabolism by facilitating the correct processing of pro-apolipoprotein AI and contributing to the assembly of high-density lipoprotein (HDL). Recent studies indicate it may function as a fine-tuner or endogenous inhibitor of certain metalloproteinases (BTPs), rather than a generalized enhancer, with a nuanced impact on extracellular matrix remodeling and potential protein–protein interaction networks relevant to cardiovascular health.

Other names
PCPE2PCOC2_HUMANPCOLCE2Procollagen C-proteinase enhancer 2
02

Mechanism of action

Acts as a modulator/enhancer (or under some contexts, inhibitor) of bone morphogenetic protein-1 (BMP1) and related metalloproteinases (BMP1/tolloid-like proteinases, BTPs) for the C-terminal cleavage of procollagen. Facilitates formation of mature collagen fibrils by enhancing propeptide removal; may also fine-tune activity of BTPs in certain contexts by direct binding and inhibition. Accelerates processing of pro-apolipoprotein AI in conjunction with BMP1, impacting HDL assembly.

03

Biological functions

Collagen bindingHeparin bindingPeptidase activator activity (enhancer of BMP1 activity on procollagen)Regulation of procollagen processing and extracellular matrix maturationModulates lipid metabolism via influence on high-density lipoprotein (HDL) biogenesis and apolipoprotein AI processing
04

Disease associations

Cardiovascular disease (modulation of HDL/cholesterol metabolism and possible impact on atherosclerosis)Extracellular matrix disorders (implicated in collagen maturation)Other (potential but not established roles, not a primary disease driver)

Beyond the preview

Go deeper on Procollagen C-endopeptidase enhancer 2 (PCPE2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Procollagen C-endopeptidase enhancer 2 (PCPE2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call